Marco Solmi
Clinician Investigator, Neuroscience
Ottawa Hospital Research Institute
Associate Professor, Psychiatry
University of Ottawa
Research Interests
Dr. Solmi, MD, Psychiatrist, PhD, is interested in evidence-based psychiatry.
His methodological focus is on meta-research and cohort studies on clinically relevant topics.
His clinical focus is on prevention/early intervention in psychiatry, physical health in those with mental disorders, and psychopharmacology.
The goal of Dr. Solmi research is to fill the gap between evidence and clinical care of mental disorders.
He has received national and international awards. He has published over 500 publications in peer-reviewed journal including World Psychiatry, JAMA Psychiatry, Lancet Psychiatry, American Journal of Psychiatry. His H-Index is over 100. He is among Clarivate Highly Cited Researchers in Psychiatry and Psychology, since 2021 (https://recognition.webofscience.com/awards/highly-cited/)
Brief Biography
Dr Marco Solmi, MD, PhD, is Associate Professor of Psychiatry and Director of Research, Psychiatry Department, uOttawa, Medical Director of On Track First Episode Psychosis program and of Eating Disorder Program at The Ottawa Hospital, Psychiatrist working at The Ottawa Hospital, Investigator at Ottawa Hospital Research Institute, Scientist at the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité University Medicine Berlin, visiting academic at University of Southampton, Centre for Innovation in Mental Health-Developmental Lab, School of Psychology, and King's College, IoPPN, Psychosis Department, London, UK, and affiliate of METRIC, the Meta-Research Innovation Center at Stanford University, US.
He is Chair of ECNP Physical And meNtal Health (PAN-Health) Thematic Working Group (TWG), and member of the Prevention of Mental Disorders And Mental Health Promotion TWG.
He is also member of the consensus core clinical and psychosocial battery committee, as well as of the new research methods for clinical/psychosocial studies committee of The Canadian Network for Research in Schizophrenia and Psychoses, of the Canadian Academy of Psychiatric Epidemiology (CAPE), of the Canadian Consortium for Early Intervention in Psychosis (CCEIP), and other national and international associations.
His main area of interest is evidence-based psychiatry, leveraging both meta-research techniques and national databases to answer clinically relevant questions. Clinically, he is most interested in prevention/early interventions for mental disorders, psychopharmacology, and physical health in those with mental disorders. Starting his academic activity in 2014, by May 2025 he has (co-) authored over 500 research publications, an H-Index of 100, and his work has been cited over 45,000 times. He is listed among Clarivate Highly Cited Researchers in Psychiatry and Psychology since 2021.
Selected Publications
https://pubmed.ncbi.nlm.nih.gov/?term=solmi+m&sort=date
Diseases, conditions and populations of interest
Research and clinical approaches
